Intranasal midazolam offers an attractive alternative for use as a sed
ative agent for medical imaging studies in children. Its convenient ad
ministration and rapid onset are significant advantages over intraveno
us and oral agents. Because of its short duration, it is effective onl
y for short procedures and as an adjunct to other sedative agents. Whe
n younger children present with such requirements, a dose of 0.2 mg/kg
has been safe and effective in our experience, We advocate its use wi
th adherence to guidelines for sedation published by the American Acad
emy of Pediatrics.